Cholesterol care | New York
Leqvio contains inclisiran, a small interfering RNA treatment that lowers LDL. A healthcare professional gives the injection initially, at three months, then every six months. It is not a self-injection pen.
Inclisiran reduces production of PCSK9 in the liver, helping LDL receptors remove cholesterol. This differs from the PCSK9-binding antibodies Repatha and Praluent. LDL lowering is not the same as a product-specific cardiovascular outcomes indication.
The August 2026 label includes adults with hypercholesterolemia, adults and children 12 and older with HeFH, and children 12 and older with HoFH. Choice depends on the diagnosis, LDL goal, other treatment, and ability to return for scheduled care.
Review LDL cholesterol and overall cardiovascular risk, including blood pressure, diabetes, smoking, and family history. Check possible secondary causes and current treatment. Discuss food and activity changes, the maximally tolerated statin, and additional therapy when indicated. Choose the medicine and administration method together, then agree on laboratory follow-up and access. If Leqvio is selected, confirm the treating site, medical benefit, authorization requirements, and injection schedule. Leqvio does not replace a statin for every patient.
Bring dated cholesterol panels, all lipid medicines and doses tried, adverse effects, kidney or liver results, and family history of early heart disease. Include any genetic testing, prior heart attack or stroke records, and insurance denials. Outside records can help avoid repeating information.
Review allergies, pregnancy plans, breastfeeding, kidney or liver conditions, and other medicines. Seek emergency care for breathing difficulty or a severe allergic reaction. New unexplained symptoms deserve prescriber advice rather than assuming they are expected. A cholesterol medicine does not treat an acute heart attack or stroke. Injection-site reactions can occur. Discuss serious allergy history and pregnancy. A clinic listing or card does not establish that the medicine is stocked.
Repeat cholesterol testing on the clinician’s schedule to assess response and adherence. Review side effects, missed doses, and refill access. Taking a cholesterol medicine does not replace laboratory monitoring or the rest of cardiovascular care. Do not stop existing medicines unless the prescriber gives a new plan.
Confirm the exact service, clinician, formulation, appointment, and refill route before booking. The evaluation, tests, medicine, administration, and follow-up may have separate costs and benefits. Ask for current estimates and required records. An FDA-approved drug or a clinic address does not establish pharmacy stock, onsite treatment, coverage, or a prescription. If access changes, contact the treating team before interrupting treatment.
Leqvio contains inclisiran, a small interfering RNA treatment that lowers LDL. A healthcare professional gives the injection initially, at three months, then every six months. It is not a self-injection pen. Inclisiran reduces production of PCSK9 in the liver, helping LDL receptors remove cholesterol. This differs from the PCSK9-binding antibodies Repatha and Praluent. LDL lowering is not the same as a product-specific cardiovascular outcomes indication.
A healthcare professional gives Leqvio initially, at three months, then every six months. This is not a monthly self-injection schedule. Confirm the next appointment, medicine acquisition, and coverage before traveling.
No. Leqvio is administered by a healthcare professional initially, again at three months, then every six months. Confirm the appointment, medicine acquisition, and medical-benefit coverage before traveling.
FDA approval, manufacturer supply, a pharmacy’s ability to fill the exact strength, and Nao Medical service availability are different questions. Confirm the exact product and refill route before a treatment change. Local supply can vary. Call before traveling, and do not interrupt prescribed treatment based on a website listing.
Repeat cholesterol testing on the clinician’s schedule to assess response and adherence. Review side effects, missed doses, and refill access. Taking a cholesterol medicine does not replace laboratory monitoring or the rest of cardiovascular care. Do not stop existing medicines unless the prescriber gives a new plan.
The visit, laboratory tests, and medicine can have different coverage rules. Ask the plan about the exact brand and indication, exclusions, prior authorization, required records, deductible, copay, and dispensing route. Bring a denial for review of its specific reason. Nao Medical or the prescriber cannot guarantee approval. Confirm current participation and costs before booking.
These are different treatments. Repatha and Praluent bind PCSK9 as monoclonal antibodies; Leqvio reduces its production through small interfering RNA. Their indications, administration, schedules, and insurance arrangements differ. Select the exact product with the clinician.
No. Leqvio contains inclisiran, a small interfering RNA treatment that reduces production of PCSK9 in the liver to help lower LDL. It may be used in a cholesterol plan with other medicines. Do not stop a tolerated statin or assume LDL lowering gives Leqvio the same product-specific cardiovascular outcomes indication as another drug.
Leqvio’s label does not give a fixed duration for every side effect. Injection-site symptoms, joint pain or bronchitis need assessment if they persist, worsen or affect daily activities. Contact the treating team rather than assuming symptoms should last until the next six-month dose. Signs of a serious allergic reaction, including facial or throat swelling or trouble breathing, need urgent medical help.
Common reactions in the adult trials included injection-site reactions, joint pain and bronchitis. Serious allergic reactions have also been reported. Adult trial rates should not be assumed to describe every child’s risk. Tell the clinician about symptoms that persist or worsen. Get urgent medical help for trouble breathing, facial or throat swelling or other signs of a serious allergic reaction.
Do not assume $12,000 is a universal price for one Leqvio injection. Ask for a written estimate separating the medicine, administration and any visit charges. Leqvio is given by a healthcare professional and commonly uses a medical benefit. Under traditional Medicare Part B, supplemental coverage can change your share; Medicare Advantage costs depend on the plan. Novartis offers conditional commercial co-pay support, which excludes government programs. Confirm the actual indication, benefit, deductible and coinsurance. The initial and three-month doses are followed by dosing every six months.
The product’s Instructions for Use give the pronunciation “leck vee oh.” Leqvio is the brand name for inclisiran. Use both names when confirming your treatment and appointment.
The review should establish the type of hypercholesterolemia, current LDL level and goal, age, prior and current lipid-lowering therapy, adherence, pregnancy or lactation considerations, and whether another approach is more appropriate.
The labeled dose is 284 mg by subcutaneous injection, given by a healthcare professional initially, at three months, and every six months after that.
A clinician should plan lipid testing and assess injection-site reactions or other concerns. The current label also addresses dosing in relation to LDL apheresis and use in specific populations.
The review should establish the type of hypercholesterolemia, current LDL level and goal, age, prior and current lipid-lowering therapy, adherence, pregnancy or lactation considerations, and whether another approach is more appropriate.
A clinician should plan lipid testing and assess injection-site reactions or other concerns. The current label also addresses dosing in relation to LDL apheresis and use in specific populations.
For a clinician-administered cholesterol injection, confirm who prescribes and administers it, how the medication will reach the clinic, the cost and your appointment. Do not arrange delivery before the clinic accepts the treatment plan.
An evaluation may lead to another medicine, more testing, a referral, or no medication change.
The health plan and dispensing pharmacy make coverage and fulfillment decisions. Prior authorization may be required.
The clinic cards below show places to start an evaluation. They do not prove that a product is stocked, dispensed, taught, or administered at that site.
Bronx
932 E 174th St, Bronx, NY 10460
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
37-15 23rd Ave, Astoria, NY 11105
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Bronx
2063A Bartow Ave, Bronx, NY 10475
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Long Island
232 W Old Country Rd, Hicksville, NY 11801
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Queens
30-07 36th Ave, Astoria, NY 11106
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Long Island
135 Mineola Blvd, Mineola, NY 11501
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Manhattan
259 1st Ave, New York, NY 10003
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
Choose a nearby clinic for an evaluation and care coordination. Before traveling, confirm the appointment type and any testing, medication teaching or treatment you need.
Explore broader cardiovascular prevention and cholesterol care at Nao Medical.
Review very high LDL levels and family history before choosing a treatment path.
Clarify symptoms and prior statin trials instead of assuming that every symptom proves intolerance.
Learn when Lp(a), ApoB, and other measurements may add useful context.
Compare a self-injected PCSK9 antibody with a clinician-administered option.